Clinical Trial: Brain Imaging and Pain in Irritable Bowel Syndrome


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Brain Imaging and Pain in Irritable Bowel Syndrome

This study is currently recruiting patients.

Sponsored by:	National Center for Complementary and Alternative Medicine (NCCAM) National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)

Purpose

This study examines the mechanisms, including brain imaging of placebo analgesia

Condition	Treatment or Intervention
Irritable Bowel Syndrome	Drug: placebo

MedlinePlus related topics: Irritable Bowel Syndrome

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Double-Blind, Factorial Assignment

Official Title: Brain Imaging and Pain: Analysis of Placebo Analgesia

Further Study Details:

Expected Total Enrollment: 50

Study start: September 2003; Study completion: September 2006

Eligibility

Ages Eligible for Study: 18 Years - 70 Years, Genders Eligible for Study: Both

Criteria

Inclusion criteria:

Irritable Bowel Syndrome
English speaking

Exclusion criteria:

Chronic pain condition other than Irritable Bowel Syndrome
Medical condition that would contraindicate use of lidocaine
Clinical criteria for fibromyalgia
Presence of systemic disease such as diabetes, thyroid, gastrointestinal or liver disease, collagen vascular disease, malignancy, focal or neurological
Seropositive HIV
Pregnancy

Location and Contact Information

Michael E Robinson, PhD 352-273-6617 merobin@ufl.edu

Florida
University of Florida, Gainesville, Florida, 32610, United States; Recruiting

Michael E Robinson, PhD 352-273-6617 merobin@ufl.edu

Study chairs or principal investigators

Michael E Robinson, PhD, Principal Investigator, University of Florida

More Information

Study ID Numbers: R01 AT001424-01
Record last reviewed: October 2004
Record first received: July 31, 2003
ClinicalTrials.gov Identifier: NCT00065754
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services